Johnson & Johnson at Bank of America Merrill Lynch Napa Healthcare Conference (Virtual) Transcript
Okay. Good afternoon, everybody, and welcome to the next presentation. I'm Bob Hopkins, here with Geoff Meacham who covers large-cap pharma and devices. And this next section, we're thrilled to have J&J here with us for a fireside chat. Joe Wolk, J&J's well-known Executive Vice President, Chief Financial Officer, is on with us; as well as Chris and Lisa and Matt from the Investor Relations team. And just a quick plug for that team. They are a phenomenal resource for investors, and I encourage everybody to take advantage of the great resource that J&J gives to all investors. So Joe, I just want to thank you for joining us this afternoon. It's a pleasure to be with you virtually.
Bob, thanks for your time and your interest as well as that, that's extended by everybody on the phone. Certainly appreciate being invited by yourself and Geoff to talk a little bit about our company today.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |